EUVIMEDSkopri EUVIMED
Crossref

A recurrent loss‐of‐function variant in DRC1 causes non‐syndromic severe asthenozoospermia with favorable intracytoplasmic sperm injection and pregnancy outcomes

Célia Tebbakh, Anne-Laure Barbotin, Guillaume Martinez iD, Angèle Boursier, Zeina Wehbe, Asma Hammouda, Nicolas Thierry-Mieg, Christophe Arnoult, Selima Fourati Ben Mustapha, Raoudha Zouari, Pierre F Ray iD, Zine-Eddine Kherraf iD

Andrology · 2025

DOI: 10.1111/andr.13837 ↗

At a glance

Journal article in Andrology, 2025. Written by Célia Tebbakh and 11 co-authors. Institution: Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, University of Grenoble Alpes, Grenoble, France. Major MEDLINE topics: Sperm Injections, Intracytoplasmic, Asthenozoospermia. Cited 7 times so far (Crossref); 27 references. Funded by: University Grenoble Alpes, National Institute of Health and Medical Research, National Center of Scientific Research.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Asthenozoospermia, characterized by reduced sperm motility, is a common cause of male infertility. Multiple morphological abnormalities of the sperm flagella (MMAF) represent a severe and genetically heterogeneous form of asthenozoospermia. Over 50 genes have been associated, but approximately half of MMAF cases remain unexplained. DRC1, a gene involved in the nexin‐dynein regulatory complex (N‐DRC), has been linked to MMAF and primary ciliary dyskinesia (PCD), often with significant variability in clinical presentation.

Objectives

His study aimed to identify novel pathogenic DRC1 variants in MMAF patients, assess their impact on sperm flagellar structure, and evaluate intracytoplasmic sperm injection (ICSI) and pregnancy outcomes. Materials and methods A cohort of 196 non‐syndromic MMAF patients was analyzed using whole exome sequencing (WES). Functional validation of candidate variants included immunofluorescence to assess protein expression and transmission electron microscopy (TEM) to identify ultrastructural abnormalities. Assisted reproductive therapy outcomes were also evaluated.

Results

WES identified a recurrent homozygous frameshift variant in DRC1 NM_145038.5: c.109dup; p.(Gln37ProfsTer30) in four patients (2%), all of North African origin, none of whom suffer from PCD‐related symptoms. The variant caused a complete absence of DRC1 protein in spermatozoa. TEM showed flagellar abnormalities, with 10% of axonemal sections revealing peripheral doublet dissociation, suggesting N‐DRC instability. ICSI resulted in a 68.5% fertilization rate, with three out of four couples successfully delivering healthy children. Discussion and conclusion The identification of a novel and recurrent pathogenic DRC1 variant broadens the mutation spectrum associated with MMAF. The absence of systemic PCD symptoms suggests that DRC1 deficiency may primarily affect spermatogenesis. Notably, the phenotypic spectrum might be influenced by the genetic background, varying across populations. Favorable ICSI outcomes, with a 68.5% fertilization rate and successful pregnancies in three out of four couples, highlight the effectiveness of assisted reproductive techniques for patients with this genetic defect.

Subjects

MeSH terms (MEDLINE)

Sperm Injections, IntracytoplasmicAsthenozoospermiaHumansMaleFemalePregnancyAdultPregnancy OutcomeLoss of Function MutationExome SequencingSperm Tail

Author keywords

MMAFasthenozoospermiaccdc164drc1flagellummale infertility

Authors and institutions

  • Institute for Advanced Biosciences, Team Genetics Epigenetics and Therapies of Infertility, University of Grenoble Alpes, Grenoble, France.
  • CHU Grenoble Alpes, UM GI-DPI, Grenoble, France.
  • CHU Lille, Laboratoire de Biologie de la Reproduction-Spermiologie-CECOS, Lille, France.
  • Development and Plasticity of the Neuroendocrine Brain, University of Lille, Lille, France.
  • CHU Grenoble Alpes, UM de Génétique Chromosomique, Grenoble, France.
  • CNRS, University of Grenoble Alpes, Grenoble, France.

ORCID profiles: Guillaume Martinez, Pierre F Ray, Zine-Eddine Kherraf

Funding

  • University Grenoble Alpes
  • National Institute of Health and Medical Research
  • National Center of Scientific Research
  • Institute of Advanced Biosciences
  • French National Research Agency
  • Institut National de la Santé et de la Recherche Médicale
  • Agence Nationale de la Recherche

Cite

APA

Tebbakh, C., Barbotin, A. L., Martinez, G., Boursier, A., Wehbe, Z., Hammouda, A., Thierry-Mieg, N., Arnoult, C., Mustapha, S. F. B., Zouari, R., Ray, P. F., & Kherraf, Z. E. (2025). A recurrent loss‐of‐function variant in DRC1 causes non‐syndromic severe asthenozoospermia with favorable intracytoplasmic sperm injection and pregnancy outcomes. Andrology. https://doi.org/10.1111/andr.13837

Vancouver

Tebbakh C, Barbotin AL, Martinez G, Boursier A, Wehbe Z, Hammouda A, et al. A recurrent loss‐of‐function variant in DRC1 causes non‐syndromic severe asthenozoospermia with favorable intracytoplasmic sperm injection and pregnancy outcomes. Andrology. 2025. doi:10.1111/andr.13837

BibTeX
@article{Tebbakh2025,
  author = {Tebbakh, Célia and Barbotin, Anne-Laure and Martinez, Guillaume and Boursier, Angèle and Wehbe, Zeina and Hammouda, Asma and Thierry-Mieg, Nicolas and Arnoult, Christophe and Mustapha, Selima Fourati Ben and Zouari, Raoudha and Ray, Pierre F and Kherraf, Zine-Eddine},
  title = {A recurrent loss‐of‐function variant in DRC1 causes non‐syndromic severe asthenozoospermia with favorable intracytoplasmic sperm injection and pregnancy outcomes},
  journal = {Andrology},
  year = {2025},
  doi = {10.1111/andr.13837}
}
Start for free →